Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Short-term Investments: 2021-2025

Historic Short-term Investments for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $136.1 million.

  • Caribou Biosciences' Short-term Investments fell 30.63% to $136.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.1 million, marking a year-over-year decrease of 30.63%. This contributed to the annual value of $193.2 million for FY2024, which is 30.40% down from last year.
  • As of Q3 2025, Caribou Biosciences' Short-term Investments stood at $136.1 million, which was down 14.26% from $158.7 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Short-term Investments registered a high of $277.7 million during Q4 2023, and its lowest value of $135.4 million during Q4 2021.
  • Over the past 3 years, Caribou Biosciences' median Short-term Investments value was $193.2 million (recorded in 2024), while the average stood at $201.2 million.
  • In the last 5 years, Caribou Biosciences' Short-term Investments soared by 46.66% in 2023 and then slumped by 30.63% in 2025.
  • Over the past 5 years, Caribou Biosciences' Short-term Investments (Quarterly) stood at $135.4 million in 2021, then surged by 39.81% to $189.3 million in 2022, then skyrocketed by 46.66% to $277.7 million in 2023, then crashed by 30.40% to $193.2 million in 2024, then tumbled by 30.63% to $136.1 million in 2025.
  • Its Short-term Investments was $136.1 million in Q3 2025, compared to $158.7 million in Q2 2025 and $179.0 million in Q1 2025.